Back to top

vaccines: Archive

Zacks Equity Research

Novavax's COVID-Flu Combo Shot Shows Strong Immune Response

NVAX's COVID-flu combo shot sparks strong immunity in seniors, fueling plans for further late-stage trials.

SNYNegative Net Change PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change

Zacks Equity Research

Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.

SNYNegative Net Change AZNNegative Net Change PFEPositive Net Change MRKNegative Net Change

Zacks Equity Research

Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike

MRNA wins FDA approval for mNexspike, a fridge-stable COVID shot, but with a narrower use label than it sought.

PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change